Table 2 Morbidity and health services usage data and percentages of pregnant women receiving folic acid and iron
Na(%) | % Receiving folic acid (n = 3,758) | Chi square p-value | % Receiving Iron (n = 4,887) | Chi square p-value | % Receiving iron + folate (n = 3,508) | Chi square p-value |
|---|---|---|---|---|---|---|
Before pregnancy | ||||||
Malaria | ||||||
Y 12,605 (57.6) | 12.8 | *** | 20.4 | *** | 11.7 | *** |
N 9,284 (42.4) | 23.1 | 25.0 | 21.9 | |||
Other diseases before pregnancy | ||||||
Y 3,795 (17.3) | 10.0 | *** | 19.6 | *** | 8.7 | *** |
N 18,094 (82.7) | 18.7 | 22.9 | 17.6 | |||
HIV | ||||||
Y 795 (3.8) | 18.0 | *** | 26.4 | ** | 16.6 | *** |
N 11,059 (43.5) | 14.8 | 21.5 | 13.4 | |||
Status unknown 10,035 (52.7) | 19.7 | 22.9 | 18.9 | |||
During pregnancy | ||||||
Parity | ||||||
First child 8,595 (39.3) | 20.3 | *** | 26.5 | *** | 18.8 | *** |
Not first child 13,294 (60.8) | 15.1 | 19.6 | 14.2 | |||
Antenatal care during pregnancy | ||||||
Y 21,658 (98.9) | 17.2 | *** | 22.4 | *** | 11.9 | *** |
N 160 (0.7) | 12.5 | 15.6 | 16.1 | |||
Number of antenatal care visits | ||||||
“0-1” 502 (2.4) | 14.5 | * | 18.5 | 13.1 | * | |
“2-3” 5017 (23.6) | 15.9 | 14.9 | 14.9 | |||
“4-8” 14387 (67.6) | 17.6 | 16.4 | 16.4 | |||
“9-15” 1392 (6.5) | 18.0 | 20.5 | 16.6 | |||
Preeclampsia/Eclampsia | ||||||
Y 8881 (4.0) | 10.2 | *** | 12.5 | 8.5 | *** | |
N 21,008 (96.0) | 17.5 | 22.7 | 16.3 | |||
Anaemia | ||||||
Y 471 (2.2) | 70.1 | *** | 74.9 | *** | 65.8 | *** |
N 21,418 (97.9) | 16.0 | 21.2 | 14.9 | |||
Malaria | ||||||
Y 4,465 (20.4) | 11.1 | *** | 14.3 | 10.2 | *** | |
N 17,424 (79.6) | 18.7 | 24.4 | 17.5 | |||
Infections | ||||||
Y 8,924 (40.8) | 12.2 | *** | 15.6 | 10.7 | *** | |
N 12,965 (59.2) | 20.6 | 27.0 | 19.7 | |||
Other diseases during pregnancy | ||||||
Y 1,074 (4.9) | 11.0 | *** | 13.7 | 9.0 | *** | |
N 20,815 (95.1) | 17.5 | 22.8 | 16.4 | |||